The legal scrutiny centers on four specific market developments. For SUNation Energy, Inc. (NASDAQ: SUNE), the investigation concerns a merger with Suniva, Inc., where shareholders face a dilution to approximately 1.8% of the combined entity. Meanwhile, Nuvalent, Inc. (NASDAQ: NUVL) is under review following its planned sale to GSK plc, which offers investors $124.00 per share in cash.

Cross Country Healthcare, Inc. (NASDAQ: CCRN) faces a July 16, 2026, shareholder vote regarding its acquisition by KL Criss Cross Intermediate, LLC, at a price of $13.25 per share. Finally, the firm is examining the merger between Bio Green Med Solution, Inc. (NASDAQ: BGMS) and Future NRG Sdn. Bhd. Shareholders holding common stock in these companies are invited to contact the firm to review their legal rights.